沈建良

2021年09月17日 15:26  点击:[]

 

沈建良博士,研究员、博士生导师。2014年于中山大学获得理学博士学位,2012- 2017年于康奈医学院从事助理研究员和博士后,2017年加入中国科学院大学温州研究院、温州医科大学眼视光学和视觉科学国家重点实验室。研究主要集中于纳米材料/技术等在生物医学领域中的探究,应用于癌症的成像和治疗、抗菌、组织工程、眼科以及其他疾病的诊疗一体化应用。已申报和授权中美专利 23项;在国际权威学术期刊已发表 100多篇相关学术论文,13ESI1%论文。研究工作以第一/通讯作者发表在 ACSNano, Nano Letters,MaterialsToday, ChemicalSocietyReviewsIScience等专业领域主流期刊上。目前主持国家自然科学基金面上和青年项目、浙江省自然科学基金重点项目、温州研究院重点专项和温州市创新自然基金等10余个科研项目。相继荣获芙兰奖(2010 2014 )ResearchMeritAward(2014)MAPTATravelAward (2017)、湖湘青年英才、浙江省高校青年优秀人才、浙江省钱江人才、温州市青年拔尖人才等国内外奖项和荣誉。此外也担任FrontiersinChemistryBiosensors客座编辑,ChineseChemicalLetters青年编委,BioactiveMaterials青年编委。    

   

课题组网站:http://wiucas.ac.cn/group/sjl/  

邮箱:shenjl@wiucas.ac.cn,shenjl@ucas.ac.cn  

   

研究兴趣:  

1)智能化纳米材料递送基因药物    

2)诊疗一体化纳米体系的生物医学应用  

3)功能化水凝胶的生物医药应用    

4)纳米免疫治疗    

   

近五年代表性论文

1.      Hou, J., Wang, S.,* Wang, B., He, X., Yoon, J.,* Shen, J.,* Sulfur-based Fluorescent ProbesforHOCl:Mechanisms,design,andapplications,CoordinationChemistryReviews, 2021. (IF= 22.315)

2.      Qian, Y., Xu,  C., Xiong, W.,  Jiang, N., Zheng, Y., He, X., Ding,  F., Lu,  X.,* Shen,  J.,* Dual Cross-Linked Organic-inorganic Hybrid Hydrogels Accelerate Diabetic Skin Wound Healing, Chemical Engineering Journal, 2021.(IF=13.273)

3.      Zeng, Q., Qian, Y., Huang, Y., Ding, F., Qi, X., Shen, J.* Polydopamine Nanoparticle- DottedFood GumHydrogel withExcellentAntibacterialActivityandRapid Shape Adaptability for Accelerating Bacteria-Infected Wound Healing, Bioactive Materials, 2021.(IF=14.593)

4.      Su,T.,Zhang,M.,Pan,W.,Qian,Y.,Zhou,Z.,He,X.,Shen,L.,Dong,W.,Qi,X.*,Shen, J.*, Mussel-inspired Agarose Hydrogel Scaffolds for Skin Tissue Engineering. Bioactive Materials 2021. (IF=14.593, ESI1%)

5.      Qi,X.,Zeng,Q.,Tong,X.,Su,T.,Xie,L.,Yuan,K.,Xu,J.,Shen, J.*Polydopamine/montmorillonite-embedded pullulan hydrogels as efficient adsorbents for removing crystal violet. Journal of Hazardous Materials. 2021.(IF= 10.588, ESI1%)

6.      Zhang, L., Mu, C., Zhang, T., Yang, D., Wang, C., Chen, Q., Tang, L., Fan, L., Shen, J.*, Li, H.*, Development of targeted therapy therapeutics to sensitize triple-negative breast cancerchemosensitivityutilizingbacteriophagephi29derivedpackagingRNA.Journalof Nanobiotechnology. 2021. (IF=10.435)

7.      Chen,G.,  Qian,Y.,  Zhang,H.,  Ullah,F.,  He,X.,  Zhou,Z.,  Fenniri,H.,* Shen, J.,* Advances in Cancer Theranostics Using Organic-Inorganic Hybrid Nanotechnology, Applied Materials Today, 2021.(IF=10.041)

8.      He, X.; Chen, H.; Xu, C.; Fan, J.; Xu, W.; Li, Y.; Deng, H.; Shen, J.* Ratiometric and colorimetric fluorescent probe for hypochlorite monitor and application for bioimaging in living cells, bacteria and zebrafish. Journal of Hazardous Materials 2020. (IF= 10.588, ESI 1%)

9.      Zhao S, Yu X, Qian Y, Chen W, Shen, J.* Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics. Theranostics. 2020. (IF= 11.556, ESI1%)

10.   Shen, J.; Zhang, W.; Qi, R.; Mao, Z.-W.; Shen, H. Engineering functional inorganic- organic hybrid systems: advances in siRNA therapeutics. Chemical Society Reviews 2018. (IF= 54.564)

11.   Shen,J.;Wolfram,J.;Ferrari,M.;Shen,H.Takingthevehicleoutofdrugdelivery.Mater Today (Kidlington) 2017. (IF=31.041)

12.   Shen,J.;Kim,H.-C.;Wolfram,J.;Mu,C.;Zhang, W.;Liu,H.;Xie,Y.;Mai,J.;Zhang,H.; Li, Z.; Guevara, M.; Mao, Z.-W.; Shen, H. A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer. Nano Letters 2017, 17, 2913-2920. (IF=11.189)  

上一条:丁峰 下一条:李晓华

关闭

Copyright ©  右江民族医学院 All Rights Reserves. 网站维护:信息与教育技术中心

备案号:桂ICP备05004626号-4 前置审核编号:桂JS200601-11